Search research articles
Contact Us
Filters
Showing results (101-110 of 123) with videos related to
Page
of 13
Sort By:
The Journal of Antimicrobial Chemotherapy
|
October 26, 2019
Effect of diabetes mellitus on TB drug concentrations in Tanzanian patients
Charles M Mtabho, Hadija H Semvua, Jossy van den Boogaard, et al.
Acta Tropica
|
December 12, 2022
Building sustainable clinical trial sites in Sub-Saharan Africa through networking, infrastructure improvement, training and conducting clinical studies: The PanACEA approach
Anna-Maria Mekota, Stephen H Gillespie, Michael Hoelscher, et al.
The European Respiratory Journal
|
February 5, 2021
Optimising pyrazinamide for the treatment of tuberculosis
Nan Zhang, Radojka M Savic, Martin J Boeree, et al.
The European Respiratory Journal
|
November 9, 2016
Shorter treatment for multidrug-resistant tuberculosis: the good, the bad and the ugly
Richard van Altena, Onno W Akkerman, Jan-Willem C Alffenaar, et al.
The Journal of Antimicrobial Chemotherapy
|
January 30, 2015
Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients
Norbert Heinrich, Rodney Dawson, Jeannine du Bois, et al.
Antimicrobial Agents and Chemotherapy
|
September 28, 2023
Drug interaction potential of high-dose rifampicin in patients with pulmonary tuberculosis
Ralf Stemkens, Veronique de Jager, Rodney Dawson, et al.
The Lancet. Respiratory Medicine
|
January 17, 2014
Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment
Sven O Friedrich, Andrea Rachow, Elmar Saathoff, et al.
Frontiers in Immunology
|
October 17, 2018
Phenotypic Changes on Mycobacterium Tuberculosis-Specific CD4 T Cells as Surrogate Markers for Tuberculosis Treatment Efficacy
Mohamed I M Ahmed, Nyanda E Ntinginya, Gibson Kibiki, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 18, 2015
A Step toward an Optimized Rifampin Dose Completed
Martin J Boeree, Andreas H Diacon, Rodney Dawson, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 6, 2015
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis
Martin J Boeree, Andreas H Diacon, Rodney Dawson, et al.
Page
of 13
Search research articles
Search
Showing results (101-110 of 123) with videos related to
Sort By:
Page
of 13
The Journal of Antimicrobial Chemotherapy
|
October 26, 2019
Effect of diabetes mellitus on TB drug concentrations in Tanzanian patients
Charles M Mtabho, Hadija H Semvua, Jossy van den Boogaard, et al.
Acta Tropica
|
December 12, 2022
Building sustainable clinical trial sites in Sub-Saharan Africa through networking, infrastructure improvement, training and conducting clinical studies: The PanACEA approach
Anna-Maria Mekota, Stephen H Gillespie, Michael Hoelscher, et al.
The European Respiratory Journal
|
February 5, 2021
Optimising pyrazinamide for the treatment of tuberculosis
Nan Zhang, Radojka M Savic, Martin J Boeree, et al.
The European Respiratory Journal
|
November 9, 2016
Shorter treatment for multidrug-resistant tuberculosis: the good, the bad and the ugly
Richard van Altena, Onno W Akkerman, Jan-Willem C Alffenaar, et al.
The Journal of Antimicrobial Chemotherapy
|
January 30, 2015
Early phase evaluation of SQ109 alone and in combination with rifampicin in pulmonary TB patients
Norbert Heinrich, Rodney Dawson, Jeannine du Bois, et al.
Antimicrobial Agents and Chemotherapy
|
September 28, 2023
Drug interaction potential of high-dose rifampicin in patients with pulmonary tuberculosis
Ralf Stemkens, Veronique de Jager, Rodney Dawson, et al.
The Lancet. Respiratory Medicine
|
January 17, 2014
Assessment of the sensitivity and specificity of Xpert MTB/RIF assay as an early sputum biomarker of response to tuberculosis treatment
Sven O Friedrich, Andrea Rachow, Elmar Saathoff, et al.
Frontiers in Immunology
|
October 17, 2018
Phenotypic Changes on Mycobacterium Tuberculosis-Specific CD4 T Cells as Surrogate Markers for Tuberculosis Treatment Efficacy
Mohamed I M Ahmed, Nyanda E Ntinginya, Gibson Kibiki, et al.
American Journal of Respiratory and Critical Care Medicine
|
August 18, 2015
A Step toward an Optimized Rifampin Dose Completed
Martin J Boeree, Andreas H Diacon, Rodney Dawson, et al.
American Journal of Respiratory and Critical Care Medicine
|
February 6, 2015
A dose-ranging trial to optimize the dose of rifampin in the treatment of tuberculosis
Martin J Boeree, Andreas H Diacon, Rodney Dawson, et al.
Page
of 13